Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosis
Top Cited Papers
Open Access
- 1 August 2006
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 50 (8) , 2640-2649
- https://doi.org/10.1128/aac.00112-06
Abstract
The molecular basis for isoniazid resistance in Mycobacterium tuberculosis is complex. Putative isoniazid resistance mutations have been identified in katG , ahpC , inhA , kasA , and ndh . However, small sample sizes and related potential biases in sample selection have precluded the development of statistically valid and significant population genetic analyses of clinical isoniazid resistance. We present the first large-scale analysis of 240 alleles previously associated with isoniazid resistance in a diverse set of 608 isoniazid-susceptible and 403 isoniazid-resistant clinical M. tuberculosis isolates. We detected 12 mutant alleles in isoniazid-susceptible isolates, suggesting that these alleles are not involved in isoniazid resistance. However, mutations in katG , ahpC , and inhA were strongly associated with isoniazid resistance, while kasA mutations were associated with isoniazid susceptibility. Remarkably, the distribution of isoniazid resistance-associated mutations was different in isoniazid-monoresistant isolates from that in multidrug-resistant isolates, with significantly fewer isoniazid resistance mutations in the isoniazid-monoresistant group. Mutations in katG 315 were significantly more common in the multidrug-resistant isolates. Conversely, mutations in the inhA promoter were significantly more common in isoniazid-monoresistant isolates. We tested for interactions among mutations and resistance to different drugs. Mutations in katG , ahpC , and inhA were associated with rifampin resistance, but only katG 315 mutations were associated with ethambutol resistance. There was also a significant inverse association between katG 315 mutations and mutations in ahpC or inhA and between mutations in kasA and mutations in ahpC . Our results suggest that isoniazid resistance and the evolution of multidrug-resistant strains are complex dynamic processes that may be influenced by interactions between genes and drug-resistant phenotypes.Keywords
This publication has 77 references indexed in Scilit:
- Detection of Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis Isolates from ChinaJournal of Clinical Microbiology, 2005
- Altered NADH/NAD + Ratio Mediates Coresistance to Isoniazid and Ethionamide in MycobacteriaAntimicrobial Agents and Chemotherapy, 2005
- Mycobacterium tuberculosis KatG(S315T) Catalase−Peroxidase Retains All Active Site Properties for Proper Catalytic FunctionBiochemistry, 2004
- Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapyDiagnostic Microbiology and Infectious Disease, 2004
- Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolatesJournal of Microbiological Methods, 2004
- Isoniazid Activation Defects in Recombinant Mycobacterium tuberculosis Catalase-Peroxidase (KatG) Mutants Evident in InhA Inhibitor ProductionAntimicrobial Agents and Chemotherapy, 2003
- rpoB Gene Mutations in Rifampin-Resistant Mycobacterium tuberculosis Identified by Polymerase Chain Reaction Single-Stranded Conformational PolymorphismEmerging Infectious Diseases, 2001
- Will tuberculosis become resistant to all antibiotics?Proceedings Of The Royal Society B-Biological Sciences, 2001
- Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosisScience, 1998
- Transmission of Tuberculosis in New York City -- An Analysis by DNA Fingerprinting and Conventional Epidemiologic MethodsNew England Journal of Medicine, 1994